| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |